Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications.

Ford JB, Albertson TE, Owen KP, Sutter ME, McKinney WB.

Pediatr Neurol. 2012 Sep;47(3):216-8. doi: 10.1016/j.pediatrneurol.2012.05.013.

0

0

0

PUBMED

8OHdG as a marker for Huntington disease progression.

Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Neurobiol Dis. 2012 Jun;46(3):625-34. doi: 10.1016/j.nbd.2012.02.012.

0

0

0

PUBMED

Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.

Dumas EM, Say MJ, Jones R, Labuschagne I, O'Regan AM, Hart EP, van den Bogaard SJ, Queller S, Justo D, Coleman A, Dar Santos RC, Dürr A, Leavitt BR, Tabrizi SJ, Roos RA, Stout JC.

J Huntingtons Dis. 2012;1(1):97-106. doi: 10.3233/JHD-2012-120010.

0

0

0

PUBMED

Perceived stress in prodromal Huntington disease.

Downing N, Smith MM, Beglinger LJ, Mills J, Duff K, Rowe KC, Epping E, Paulsen JS; PREDICT-HD Investigators of Huntington Study Group..

Psychol Health. 2012;27(2):196-209. doi: 10.1080/08870446.2010.529141.

0

0

0

PUBMED

Shaping the role of mitochondria in the pathogenesis of Huntington's disease.

Costa V, Scorrano L.

EMBO J. 2012 Apr 18;31(8):1853-64. doi: 10.1038/emboj.2012.65. Review.

0

0

0

PUBMED

Huntington's disease.

Ha AD, Fung VS.

Curr Opin Neurol. 2012 Aug;25(4):491-8. doi: 10.1097/WCO.0b013e3283550c97. Review.

0

0

0

PUBMED

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, André VM, Cepeda C, Watson JB, Levine MS.

J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011.

0

0

0

PUBMED

Juvenile Huntington's disease presenting as difficult-to-treat seizure and the first episode of psychosis.

Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC.

Gen Hosp Psychiatry. 2012 Jul-Aug;34(4):436.e9-11. doi: 10.1016/j.genhosppsych.2012.02.008.

0

0

0

PUBMED

PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.

Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, La Spada AR.

Sci Transl Med. 2012 Jul 11;4(142):142ra97. doi: 10.1126/scitranslmed.3003799.

0

0

0

PUBMED

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.

Prime ME, Andersen OA, Barker JJ, Brooks MA, Cheng RK, Toogood-Johnson I, Courtney SM, Brookfield FA, Yarnold CJ, Marston RW, Johnson PD, Johnsen SF, Palfrey JJ, Vaidya D, Erfan S, Ichihara O, Felicet

J Med Chem. 2012 Feb 9;55(3):1021-46. doi: 10.1021/jm201310y.

0

0

0

PUBMED

Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.

Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, Chesselet MF.

Mol Neurodegener. 2012 Apr 4;7:12. doi: 10.1186/1750-1326-7-12.

0

0

0

PUBMED

Measures of growth in children at risk for Huntington disease.

Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P.

Neurology. 2012 Aug 14;79(7):668-74. doi: 10.1212/WNL.0b013e3182648b65.

0

0

0

PUBMED

Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease.

Sarantos MR, Papanikolaou T, Ellerby LM, Hughes RE.

J Huntingtons Dis. 2012;1(2):195-210. doi: 10.3233/JHD-120033.

0

0

0

PUBMED

Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.

Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C, Masliah E, Leavitt BR, Thomas EA.

Hum Mol Genet. 2012 Jul 15;21(14):3097-111. doi: 10.1093/hmg/dds132.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy